Elevation Oncology Inc (ELEV)
0.58
-0.04
(-6.22%)
USD |
NASDAQ |
Nov 14, 11:57
Elevation Oncology Shareholders Equity (Quarterly): 69.36M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 69.36M |
| June 30, 2024 | 80.92M |
| March 31, 2024 | 75.82M |
| December 31, 2023 | 54.81M |
| September 30, 2023 | 62.42M |
| June 30, 2023 | 72.18M |
| March 31, 2023 | 33.76M |
| December 31, 2022 | 49.03M |
| Date | Value |
|---|---|
| September 30, 2022 | 67.12M |
| June 30, 2022 | 104.68M |
| March 31, 2022 | 123.87M |
| December 31, 2021 | 140.70M |
| September 30, 2021 | 149.63M |
| June 30, 2021 | 155.34M |
| March 31, 2021 | -28.10M |
| December 31, 2020 | -23.08M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-28.10M
Minimum
Mar 2021
155.34M
Maximum
Jun 2021
74.28M
Average
70.77M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.30M |
| Total Liabilities (Quarterly) | 36.95M |